Sindrom posteriorne reverzibilne encefalopatije

Dejan Ž Kostić; Biljana Brkić-Georgievski; Aleksandar Jovanovski; Smiljana Kostić; Dražen Ivetić; Leposava Sekulović

doi:10.2298/6179

Dejan Ž Kostić
Biljana Brkić-Georgievski Special Hospital for Cerebrovascular Diseases „Sveti Sava“, Belgrade, Serbia
Aleksandar Jovanovski Institute of Radiology Military Medical Academy, Belgrade, Serbia
Smiljana Kostić Clinic for Neurology Military Medical Academy, Belgrade, Serbia
Dražen Ivetić Clinic for Neurosurgery, Military Medical Academy, Belgrade, Serbia
Leposava Sekulović Institute of Radiology, Military Medical Academy, Belgrade, Serbia Faculty of Medicine of the Military Medical Academy, University of Defence, Belgrade, Serbia

DOI: https://doi.org/10.2298/6179

Ključne reči: brain diseases||, ||mozak, bolesti, syndrome||, ||sindrom, diagnosis||, ||dijagnoza, treatment outcome||, ||lečenje, ishod,

Sažetak

Uvod. Sindrom posteriorne reverzibilne encefalopatije (PRES) karakterišu sledeći simptomi: epi napadi, poremećaji svesti i/ili vida, povraćanje, mučnina i fokalni neurološki znaci. Dijagnostičko snimanje obuhvata pregled magnetnom rezonancijom (MR) i kompjuterizovanom tomografijom (CT) gde se moždani edem vizuelizuje bilateralno i simetrično, preovlađuje posteriorno, parijetalno i okcipitalno. Prikaz bolesnika. Prikazali smo bolesnika starog 73 godine, dugogodišnjeg hipertoničara i bubrežnog bolesnika kod koga se razvio PRES sa simptomatologijom zadnje lobanjaske jame i verifikovanim promenama moždane bele mase na CT i MR, obostrano na svim režnjevima mozga. Nakon dve nedelje lečenja (antihipertenzivi, hipolipemici i rehidraciona terapija) nastupilo je kliničko poboljšanje bez ikakvih komplikacija i sa kompletnom rezolucijom promena bele moždane mase viđenim na CT i MR. Zaključak. PRES je reverzibilni sindrom čiji simptomi se povlače za nekoliko dana do nekoliko nedelja, ukoliko se rano postavi dijagnoza i odgovarajuće lečenje počne bez odlaganja.

Biografija autora

Dejan Ž Kostić

asistent

kontakt telefon 063 69 69 79

Reference

Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996; 334(8): 494−500.

Fugate JE, Claassen DO, Cloft HJ, Kallmes DF, Kozak OS, Rab-instein AA. Posterior reversible encephalopathy syndrome: as-sociated clinical and radiologic findings. Mayo Clin Proc 2010; 85(5): 427−32.

Bartynski WS. Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features. AJNR Am J Neuroradiol 2008; 29(6): 1036−42.

Bartynski WS. Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema. AJNR Am J Neuroradiol 2008; 29(6): 1043−9.

Legriel S, Pico F, Azoulay E. Understand ing posterior reversible encephalopathy syndrome. In: Vincent JL, editor. Annual Up-date in Intensive Care and Emergency Medicine. Berlin: Springer: 2011. p. 631−53.

Schwartz RB, Jones KM, Kalina P, Bajakian RL, Mantello MT, Garada B, et al. Hypertensive encephalopathy: findings on CT, MR imaging, and SPECT imaging in 14 cases. AJR Am J Roentgenol 1992; 159(2): 379−83.

Schwartz RB, Bravo SM, Klufas RA, Hsu L, Barnes PD, Robson CD, et al. Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MR findings in 16 cases. AJR Am J Roentgenol 1995; 165(3): 627−31.

Casey SO, Sampaio RC, Michel E, Truwit CL. Posterior reversible encephalopathy syndrome: utility of fluid-attenuated inversion recovery MR imaging in the detection of cortical and subcorti-cal lesions. AJNR Am J Neuroradiol 2000; 21(7): 1199−206.

Servillo G, Striano P, Striano S, Tortora F, Boccella P, De RE, et al. Posterior reversible encephalopathy syndrome (PRES) in criti-cally ill obstetric patients. Intensive Care Med 2003; 29(12): 2323−6.

Kozak OS, Wijdicks EF, Manno EM, Miley JT, Rabinstein AA. Status epilepticus as initial manifestation of posterior reversible encephalopathy syndrome. Neurology 2007; 69(9): 894−7.

Yoon SD, Cho BM, Oh SM, Park SH, Jang IB, Lee JY. Clinical and radiological spectrum of posterior reversible encephalopa-thy syndrome. J Cerebrovasc Endovasc Neurosurg. 2013; 15(3): 206−13.

Lee VH, Wijdicks EF, Manno EM, Rabinstein AA. Clinical spec-trum of reversible posterior leukoencephalopathy syndrome. Arch Neurol 2008; 65(2): 205−10.

Burnett MM, Hess CP, Roberts JP, Bass NM, Douglas VC, Josephson SA. Presentation of reversible posterior leukoencephalopathy syndrome in patients on calcineurin inhibitors. Clin Neurol Neurosurg 2010; 112(10): 886−91.

Legriel S, Schraub O, Azoulay E, Hantson P, Magalhaes E, Coquet I, et al. Determinants of recovery from severe posterior reversi-ble encephalopathy syndrome. PLoS One 2012; 7(9): e44534.

Marrone LC, Marrone BF, de la Puerta RJ, Gadonski G, da Costa JC. Gemcitabine monotherapy associated with posterior reversible encephalopathy syndrome. Case Rep Oncol 2011; 4(1): 82−7.

Bartynski WS, Boardman JF, Zeigler ZR, Shadduck RK, Lister J. Posterior reversible encephalopathy syndrome in infection, sepsis, and shock. AJNR Am J Neuroradiol 2006; 27(10): 2179−90.

Loh HH, Tan CH. Acute renal failure and posterior reversible encephalopathy syndrome following multiple wasp stings: a case report. Med J Malaysia 2012; 67(1): 133−5.

Luiz C, Porcello M. Posterior Reversible Encephalopathy Syn-drome Following a Scorpion Sting. J Neuroimaging 2013; 23: 535–6.

Bartynski WS, Boardman JF, Zeigler ZR, Shadduck RK, Lister J. Posterior reversible encephalopathy syndrome in infection, sepsis, and shock. AJNR Am J Neuroradiol 2006; 27(10): 2179−90.

McKinney AM, Short J, Truwit CL, McKinney ZJ, Kozak OS, San-taCruz KS, et al. Posterior reversible encephalopathy syn-drome: incidence of atypical regions of involvement and imag-ing findings. AJR Am J Roentgenol 2007; 189(4): 904−12.

Covarrubias DJ, Luetmer PH, Campeau NG. Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion-weighted MR images. AJNR Am J Neuroradiol 2002; 23(6): 1038−48.

Kastrup O, Schlamann M, Moenninghoff C, Forsting M, Goericke S. Posterior Reversible Encephalopathy Syndrome: The Spec-trum of MR Imaging Patterns. Clin Neuroradiol 2014; (In Press)

Lee S, Kim SH, Lee SH, Baek HJ, Shon HS, Kim SS. Serial MR spectroscopy in relapsing reversible posterior leukoencephalo-pathy syndrome. Neurologist 2009; 15(6): 338−41.

Alexander AL, Lee JE, Lazar M, Field AS. Diffusion tensor im-aging of the brain. Neurotherapeutics 2007; 4(3): 316−29.

Sonneville R, Klein IF, Wolff M. Update on investigation and management of postinfectious encephalitis. Curr Opin Neurol 2010; 23(3): 300−4.

Thurnher MM, Post MJ, Rieger A, Kleibl-Popov C, Loewe C, Schindler E. Initial and follow-up MR imaging findings in AIDS-related progressive multifocal leukoencephalopathy treated with highly active antiretroviral therapy. AJNR Am J Neuroradiol 2001; 22(5): 977−84.

McKinney AM, Sarikaya B, Gustafson C, Truwit CL. Detection of microhemorrhage in posterior reversible encephalopathy syn-drome using susceptibility-weighted imaging. AJNR Am J Neuroradiol 2012; 33(5): 896−903.

O'Sullivan M. Leukoaraiosis. Pract Neurol 2008; 8(1): 26−38.

Hugonnet E, Da Ines D, Boby H, Claise B, Petitcolin V, Lannareix V, Garcier JM. Posterior reversible encephalopathy syndrome (PRES): features on CT and MR imaging. Diagn Interv Imag-ing 2013; 94(1): 45−52.

Culebras A, Kase CS, Masdeu JC, Fox AJ, Bryan RN, Grossman CB, et al. Practice guidelines for the use of imaging in transient ischemic attacks and acute stroke. A report of the Stroke Council, American Heart Association. Stroke 1997; 28(7): 1480−97.

Matthews PM, Tampieri D, Berkovic SF, Andermann F, Silver K, Chityat D, et al. Magnetic resonance imaging shows specific abnormalities in the MELAS syndrome. Neurology 1991; 41(7): 1043−6.

Pomper MG, Miller TJ, Stone JH, Tidmore WC, Hellmann DB. CNS vasculitis in autoimmune disease: MR imaging findings and correlation with angiography. AJNR Am J Neuroradiol 1999; 20(1): 75−85.

Kallenberg K, Schulz-Schaeffer WJ, Jastrow U, Poser S, Meissner B, Tschampa HJ, et al. Creutzfeldt-Jakob disease: comparative analysis of MR imaging sequences. AJNR Am J Neuroradiol 2006; 27(7): 1459−62.